Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer

PURPOSE: The aim of the study was to compare the difference in survival between invasive ductal (IDC) and lobular carcinoma (ILC). METHODS: Data of patients (n = 1843) with a hormone receptor-positive, HER2-negative, pT1-3 IDC or ILC cancer without distant metastasis, treated at the Ghent University...

Descripción completa

Detalles Bibliográficos
Autores principales: Göker, Menekse, Denys, Hannelore, Hendrix, An, De Wever, Olivier, Van de Vijver, Koen, Braems, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664297/
https://www.ncbi.nlm.nih.gov/pubmed/37993928
http://dx.doi.org/10.1186/s13058-023-01745-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664297/
https://www.ncbi.nlm.nih.gov/pubmed/37993928
http://dx.doi.org/10.1186/s13058-023-01745-x

Ejemplares similares